The initial consultation

The initial consultation is the beginning of a structured journey based on objective data: the first step in developing a personalized therapeutic strategy.

The initial consultation:
the starting point

The specialist consultation for vitiligo is a key moment in the therapeutic journey.

Includes:

Detailed
medical history
Detailed
clinical
evaluation
Wood’s lamp
examination
Photographic
documentation
Assessment of the
disease activity status

Follow-up consultations:
monitor, adapt, consolidate

Follow-up consultations after the initial visit are scheduled at variable intervals, generally every 2–4 months, depending on the stage of the disease and the individual response to treatment. During each follow-up, the following are carried out:

clinical
evaluation of
the vitiligo
condition
observation
of the skin with
Wood’s lamp
photographic
comparison with
previous
images
reassessment
of the disease’s
immune
activity
possible
adjustment of
systemic and
topical therapy

This approach makes it possible to:

intervene early
in case of reactivation

avoid unnecessary treatments
or those no longer indicated

consolidate the results
achieved over time

Discover the costs

A team dedicated
to therapeutic continuity

The vitiligo treatment journey is managed by a team of specialist physicians directly trained in the ImmunoNova Protocol, working in constant clinical collaboration and methodological alignment.

In particular, the team consists of:

Dr. Giovanni Menchini (initial consultation)
Dr. Chiara Scacciati
Dr. Fabrizio Lombardo

All physicians work within Dermacademy’s vitiligo team and share a common clinical method based on:

objective assessment of disease activity
rigorous application of the protocol
continuous personalization of therapy

This organization allows patients to be followed over time with therapeutic consistency, ensuring continuity, safety, and clinical quality.

Why follow-up is essential in vitiligo treatment

There are no static protocols in vitiligo treatment.

An effective therapy is one that adapts to the evolution of the patient’s immune system.

Regular monitoring makes it possible to:

distinguish active phases from stable ones
properly adjust phototherapy and topical treatments
avoid over- or undertreatment
improve therapeutic adherence
achieve more stable long-term results

In the ImmunoNova Protocol, continuity of follow-up visits is an integral part of the treatment, just as important as medications or phototherapy.

Before

After